Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOPIN: PHP with Ipilimumab + Nivolumab in Uveal Melanoma
NCT04283890Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2019
- Primary completion
- Dec 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ipilimumab, nivolumab in Uveal melanoma (UM), sponsored by Leiden University Medical Center. Started Dec 2019; status: active, not recruiting.
02
Drugs
ipilimumabnivolumab
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT04283890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04283890.